One year in review 2018: novelties in the treatment of rheumatoid arthritis

被引:1
|
作者
Bortoluzzi, A. [1 ]
Furini, F. [1 ]
Generali, E. [2 ]
Silvagni, E. [1 ]
Luciano, N. [3 ]
Scire, C. A. [1 ,4 ]
机构
[1] Univ Ferrara, Rheumatol Unit, Dept Med Sci, Ferrara, Italy
[2] Humanitas Clin & Res Ctr, Div Rheumatol & Clin Immunol, Milan, Italy
[3] Univ Pisa, Rheumatol Unit, Dept Clin & Expt Med, Pisa, Italy
[4] Italian Soc Rheumatol, Epidemiol Unit, Milan, Italy
关键词
rheumatoid arthritis; biologics; treatment; management; TUMOR-NECROSIS-FACTOR; MODIFYING ANTIRHEUMATIC DRUGS; LONG-TERM EFFECTIVENESS; RANDOMIZED PHASE IIB; LOW DISEASE-ACTIVITY; DOUBLE-BLIND; OPEN-LABEL; MONOCLONAL-ANTIBODY; CLINICAL-OUTCOMES; INADEQUATE RESPONSE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The current approach to treatment of rheumatoid arthritis (RA) includes early and aggressive intervention aiming to reach early and persistent low disease activity and remission. New drugs have improved the therapeutic armamentarium of rheumatologists, providing new options for patients. Beyond these innovations, new evidence has improved the safety of therapies and provided tools for the optimisation of long-term management of RA. This paper reviews the most relevant studies published over the last year in the field of treatment of RA.
引用
下载
收藏
页码:347 / 361
页数:15
相关论文
共 50 条
  • [1] One year in review: novelties in the treatment of rheumatoid arthritis
    Guidelli, G. M.
    Barskova, T.
    Brizi, M. G.
    Lepri, G.
    Parma, A.
    Talarico, R.
    Cantarini, L.
    Frediani, B.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (01) : 102 - 108
  • [2] One year in review 2017: novelties in the treatment of rheumatoid arthritis
    Ferro, F.
    Elefante, E.
    Luciano, N.
    Talarico, R.
    Todoerti, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (05) : 721 - 734
  • [3] One year in review 2016: novelties in the treatment of rheumatoid arthritis
    Calabro, A.
    Caterino, A. L.
    Elefante, E.
    Valentini, V.
    Vitale, A.
    Talarico, R.
    Cantarini, L.
    Frediani, B.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (03) : 357 - 372
  • [4] One year in review 2019: novelties in the treatment of rheumatoid arthritis
    Silvagni, E.
    Di Battista, M.
    Bonifacio, A. F.
    Zucchi, D.
    Governato, G.
    Scire, C. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (04) : 519 - 534
  • [5] One year in review 2021: novelties in the treatment of rheumatoid arthritis
    Silvagni, E.
    Sakellariou, G.
    Bortoluzzi, A.
    Giollo, A.
    Ughi, N.
    Vultaggio, L.
    Scire, C. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (04) : 705 - 720
  • [6] One year in review 2020: novelties in the treatment of rheumatoid arthritis
    Silvagni, E.
    Giollo, A.
    Sakellariou, G.
    Ughi, N.
    D'Amico, M. E.
    Scire, C. A.
    Huizinga, T. W. J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (02) : 181 - 194
  • [7] One year in review 2018: pathogenesis of rheumatoid arthritis
    Calabresi, E.
    Petrelli, F.
    Bonifacio, A. F.
    Puxeddu, I.
    Alunno, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (02) : 175 - 184
  • [8] One year in review 2018: ultrasonography in rheumatoid arthritis and psoriatic arthritis
    Zabotti, Alen
    Mandl, Peter
    Zampogna, Giuseppe
    Dejaco, Christian
    Iagnocco, Annamaria
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : 519 - 525
  • [9] One year in review: the pathogenesis of rheumatoid arthritis
    Picerno, V.
    Ferro, F.
    Adinolfi, A.
    Valentini, E.
    Tani, C.
    Alunno, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (04) : 551 - 558
  • [10] One year in review 2018: psoriatic arthritis
    Calabresi, E.
    Monti, S.
    Governato, G.
    Carli, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (02) : 167 - 178